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The aim of this study was to evaluate whether effects of
environmental estrogens on fish growth and reproduction may be
mediated via modulating the growth hormone (GH)/insulin-like
growth factor I (IGF-I) system. To this end, developing male and
female monosex populations of tilapia were exposed to 17a-
ethinylestradiol (EE2) at 5 and 25 ng EE2/l water from 10-day
postfertilization (DPF) until 100 DPF. Under exposure to both EE2
concentrations, sex ratio shifted toward more females and body
length, and weight were significantly reduced in males. The growth-
reducing effect was associated with significant changes in hepatic
IGF-I expression, both in males and females and with significant
alterationsof IGF-ImRNAandGHmRNAin the brain.The changes
in IGF-I and GH mRNA were accompanied by altered estrogen
receptor a (ERa) expression in brain and liver. These findings point
to an influence of estrogenic exposure on the endocrine GH/IGF-I
axis. In addition, the EE2 treatment resulted in significant changes
of ERa and IGF-I expression in ovaries and testis, suggesting that
the estrogens interact not only with the endocrine but also with the
autocrine/paracrine part of the IGF-I system. Overall, our results
provide evidence that EE2 at environmentally relevant concen-
trations is able to interfere with the GH/IGF-I system in bony fish
and that the impairing effects of estrogens reported on fish growth
and reproductive functions may rather result from a cross talk
between the sex steroid and the IGF-I system than be toxicological.
Key Words: IGF-I; growth hormone; development; liver; brain;
ovary; testis; teleost.
Endocrine disrupting compounds (EDCs) have the potential
to disrupt internal homeostasis and hormone-controlled
physiological processes such as development, growth, stress
responses, sexual differentiation, or reproduction. Many EDCs
end up in the aquatic environment and therefore primarily
affect aquatic organisms including fish. Numerous effects of
EDCs on fish from all over the world have been described,
such as deformities and defects in fish larvae from the North
Sea (Dethlefsen et al., 1996), feminization of male fish near
sewage treatment outlets in the United Kingdom (Gross-
Sorokin et al., 2006; Sumpter and Jobling, 1995), significant
alterations of the steroid system of carps from the Ebro River
(Lavado et al., 2004), and impaired growth in male mosquito
fish in Western Australia (Game et al., 2006). Furthermore,
exposure to estrogenic compounds at low concentrations can
lead to growth impairment, as it has been shown for rainbow
trout (Ashfield et al., 1998) and zebra fish (Schäfers et al.,
2007). However, it is unknown whether the mechanisms
underlying the growth impairment represents a general toxico-
logical stress rather than an endocrine disrupting effect.
Insulin-like growth factor I (IGF-I) is crucially involved in
the regulation of growth, differentiation, and reproduction by
selectively promoting mitogenesis and differentiation (Jones
and Clemmons, 1995; Reinecke and Collet, 1998). Among the
nonmammalian classes of vertebrates, bony fish are the mostly
studied with respect to IGF-I (Reinecke et al., 2005; Wood
et al., 2005) mainly due to their unique development from the
larval to the adult life, their high growth potential, and to their
importance in aquaculture. As in mammals, IGF-I is mainly
produced in fish liver––the principal source of the circulating
(endocrine) IGF-I––under the influence of growth hormone
(GH). In addition, IGF-I is expressed in parenchymal cells of
numerous extrahepatic sites of adult (Reinecke et al., 1997) and
developing (Berishvili et al., 2006a,b; Perrot et al., 1999;
Radaelli et al., 2003) fish and most likely stimulates organ-
specific functions by paracrine/autocrine mechanisms. There is
increasing evidence that GH stimulates the expression of IGF-I
not only in fish liver but also in extrahepatic sites (Biga et al.,
2004; Eppler et al., 2007; Vong et al., 2003).
From in vivo and in vitro studies with adults of different fish
species, initial evidence has been provided on an interaction
between the estrogen and IGF-I system. In particular,
17b-estradiol (E2) appears to be able to downregulate hepatic
IGF-I expression (Carnevali et al., 2005; Davis et al., 2007;
Filby et al., 2006; Lerner et al., 2007; Riley et al., 2004) or
serum IGF-I (Arsenault et al., 2004; Davis et al., 2007;
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McCormick et al., 2005). In a recent study on tilapia,
Oreochromis niloticus, we could show that early life exposure
to elevated concentrations of 17a-ethinylestradiol (EE2),
a major constituent of contraceptive pills, has long-lasting
consequences on growth, IGF-I serum levels, and IGF-I
expression in liver as well as in gonads (Shved et al., 2007).
These data suggest that estrogen effects on the GH/IGF-I
system may be more pronounced during fish development, that
is, in the phase of rapid growth as well as of sexual
differentiation and gonad development.
In the previous study, we used rather high EE2 concen-
trations (Shved et al., 2007) in order to establish principally
whether the estrogen and GH/IGF-I system do interact. The
effects observed with this approach, however, may reflect
a general toxic stress situation rather than a specific endocrine
disrupting mode of action. The aim of the present study was to
investigate whether low estrogen exposure at concentrations at
environmentally observed levels are able to disrupt the GH/
IGF-I system and growth in developing tilapia. Thus, our
hypothesis was that the EE2 impact on the GH/IGF-I system as
observed at high estrogen doses is still valid at low,
environmentally relevant concentrations.
It is known that EDC exposure of fish during critical stages
of gonad development can induce permanent, organizational
changes in sexual differentiation; however, currently very few
studies have addressed whether early life exposure to EDCs,
particularly estrogens, can permanently alter functioning of
other physiological systems in fish (Lerner et al., 2007; Milston
et al., 2003).
Concentrations of EE2 in the aquatic environment in the low
nanogram per liter range have been observed in numerous
countries. In Germany, concentrations of EE2 in rivers were up
to 5 ng/l and in waste water treatment plants effluents ranged
from 9 (Kuch and Ballschmiter, 2001) to 15 ng/l (Ternes et al.,
1999). Similarly, in France and the Netherlands, 3–4 ng EE2/l
were measured in coastal water and rivers and 4–8 ng EE2/l in
effluents (Belfroid et al., 1999; Cargouët et al., 2004). EE2
concentrations in effluents in the United Kingdom were around
7 ng/l (Desbrow et al., 1998) and in a river in Taipei around 15
ng EE2/l (Chen et al., 2007). United States Stream Data 1999–
2000 give the EE2 content in 139 streams across 30 states
(Kolpin et al., 2002) between 5 and 273 ng EE2/l, and in
Canada, up to 42 ng EE2/l were reported in effluents (Ternes
et al., 1999).
In the present study, female and male ‘‘monosex’’
populations of tilapia (O. niloticus) were experimentally
exposed to 5 and 25 ng EE2/l––concentrations well within
the range found in the environment––from 10-day postfertili-
zation (DPF) until 100 DPF, a period covering the sensitive
period of gonadal development and ranging until the end of
puberty. Male and female fish were investigated at 30, 50, 75,
and 100 DPF. The question was assessed whether EE2
exposure during development exerts acute and lasting effects
on the expression of GH mRNA in pituitary and of IGF-I
mRNA in liver and extrahepatic sites, that is, gonad and brain.
Finally, the expression of estrogen receptor a (ERa) that is
considered to be the ER subtype most responsive to estrogen
(e.g., Filby et al., 2007; Marlatt et al., 2008; Menuet et al.,
2004) was also measured in the organs studied.
MATERIALS AND METHODS
Generation and maintenance of fish. To allow sex-differentiated analysis
of very early stages, monosex breedings of O. niloticus generated as described
before (Baroiller et al., 1995, 1999) were investigated. In brief, suitable sires
from sex-reversed fish were selected by progeny testing and then used to
produce monosex populations that were used for our experiments. Fish were
kept at the Aquaculture Experimental Facilities of CIRAD (Montpellier,
France) where also the exposure experiments were performed.
Experimental conditions. Two monosex populations XX and XY (n¼ 400
each) of tilapia were incubated in 40-l aquaria at 27C ± 1C during a period of
10–100 DPF with EE2 (Sigma, Deisenhofen, Germany) at the nominal
concentrations of 5 or 25 ng/l and with 0.4% ETOH in water (solvent control).
Each group was run in duplicates. Prior to treatment, aquaria were saturated with
EE2 at a concentration of 1000 ng/l during 1 week. During the exposure, water
in all aquaria (controls, 5 ng EE2/l, 25 ng EE2/l) was renewed every 48 h. The
EE2 concentrations in all aquaria were repetitively determined after 36 h.
Fish sampling and tissue preparation. At the age of 30, 50, 75, and 100
DPF fish were anesthetized with 2-phenoxy-ethanol (Sigma) added to water,
and weight and length were measured. With the older stages (75 and 100 DPF),
sex was additionally individually assured at sampling by external inspection of
the papilla and internal inspection of the gonads. Tissue specimens (liver, brain,
gonads) were excised and transferred into 1.5 ml of RNAlater (Ambion, Austin,
TX), kept at 4C and stored at  20C until use. Total RNA was extracted
using TRIzol reagent (Invitrogen, Merelbeke, Belgium), resuspended in
diethylpyrocarbonate-treated water, and photospectrometrically quantified. The
following sample numbers were used for real-time PCR: control (male: 30 DPF
n ¼ 8, 50 DPF n ¼ 12, 75 DPF n ¼ 11, 100 DPF n ¼ 12; female: 30 DPF n ¼
10, 50 DPF n ¼ 10, 75 DPF n ¼ 11, 100 DPF n ¼ 12) and EE2 exposed
(5 ngEE2/l, male: 30 DPF n ¼ 8, 50 DPF n ¼ 8, 75 DPF n ¼ 7, 100 DPF n ¼ 8;
female: 30 DPF n ¼ 9, 50 DPF n ¼ 8, 75 DPF n ¼ 10, 100 DPF n ¼ 8; 25 ng
EE2/l, male: 30 DPF n ¼ 7, 50 DPF n ¼ 7, 75 DPF n ¼ 8, 100 DPF n ¼ 8;
female: 30 DPF n ¼ 7, 50 DPF n ¼ 8, 75 DPF n ¼ 9, 100 DPF n ¼ 8).
Solid-phase extraction/enzyme-linked immunosorbent assay. To assess
the actual EE2 concentration during the experiment, water samples were
collected from the control and exposure aquaria. The EE2 ELISA kit
(Ecologiene, Japan, purchased from Biosense Laboratories, Bergen, Norway)
was used to detect EE2 in water samples. In order to concentrate the EE2
content to amounts detectable by the assay, water samples were subjected to
solid-phase extraction, according to Ternes et al. (1999). In all, 100 mg
LiChrolut EN and 200 mg RP-18 cartridges (Merck, Zug, Switzerland) were
first conditioned with the series of passing––hexane, acetone, methanol, and
water (pH 3.0). Prefiltered water samples (200 ml) were loaded under gentle
vacuum pressure (1l/1h). Loaded cartridges were dried under nitrogen flow for
60 min. Elution was performed with 4 ml acetone in silanized amber vials
(Supelco, Gland, Switzerland). Acetone was evaporated to dryness under
nitrogen stream, and EE2 was reconstituted in 0.5 ml ethanol. Resulting
samples were analyzed by enzyme-linked immunosorbent assay.
Design of primers and probes for real-time PCR. Based on the mRNA
sequences of O. niloticus b-actin as housekeeping gene (Hwang et al., 2003),
O. mossambicus IGF-I (Reinecke et al., 1997), O. niloticus GH (Ber and
Daniel, 1992), and O. niloticus ERa (Chang et al., 1999), primers (b-actin:
sense GCCCCACCTGAGCGTAAATA, antisense AAAGGTGGACAGGAG-
GCCA, probe TCCGTCTGGATCGGAGGCTTCATC; IGF-I: sense
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TCTGTGGAGAGCGAGGCTTT, antisense CACGTGACCGCCTTGCA,
probe ATTTCAATAAACCAACAGGCTATGGCCCCA; GH: sense TCGAC-
AAACACGAGACGCA, antisense CCCAGGACTCAACCAGTCCA, probe
CGCAGCTCGGTCCTGAAGCTG, and ERa: sense CAAGTGGTGGAGGA-
GGAAGATC, antisense CTCAGCACCCTGGAGCAG, probe CTGATCAG-
GTGCTCCTC) were created as described previously (Caelers et al., 2004;
Shved et al., 2007). Oligonucleotides were designed with Primer Express
software version 1.5 (PE Biosystems, Foster City, CA).
Quantitation of IGF-I and ERa expression by two-step real-time reverse
transcriptase-PCR TaqMan system. Total RNA was treated with 1 U of RQ1
RNAse-free DNAse (Catalys AG, Wallisellen, Switzerland). Single-stranded
cDNA was synthesized from 800 ng total RNA using 13 TaqMan reverse
transcription buffer, MgCl2 (5.5mM), 1.25 U/ll of moloney murine leukemia
virus reverse transcriptase, 2.5lM of random hexamers primers, 0.4 U/ll
ribonuclease inhibitor, 500lM each dNTP (Applied Biosystems, Rotkreuz,
Switzerland) for 10 min at 25C, 30 min at 48C, and 5 min at 95C. In all, 2 ll
cDNA obtained from 10 ng/ll total RNA were subjected, in duplicates, to real-
time PCR using an Absolute QPCR low ROX Mix (ABgene, Epsom, UK)
including Thermo-Start DNA polymerase, 300nM of each primer, and 150nM
of the fluorogenic probe. Amplification was performed with a total reaction
volume of 10 ll in a MicroAmp Fast Optical 96-Well Reaction Plate (Applied
Biosystems). Reactions were run on the ABI 7500 Fast Real-Time PCR System
(Applied Biosystems) with the following conditions: 95C for 15 min of the
enzyme activation followed by 40 cycles of 95C for 15 s and 60C for 1 min.
Relative quantification of treatment effects using the DDCT method.
The relative gene expression ratios between EE2-exposed and control fish were
calculated using the comparative CT method (DDCT method). For validation of
quantitative PCR assays, the CT values were plotted against the logarithms of
the dilution factors and the slope was determined. Relative changes induced by
EE2 exposure were calculated using the formula 2DDCT with DCT ¼ CT (target
gene)  CT (internal control) and DDCT ¼ DCT (treated group)  DCT
(untreated control). Thus, all experimental data are expressed as an n-fold
difference relative to the calibrator (untreated control). Statistical significance
was calculated using Mann-Whitney rank sum test with an exact p value.
Statistical analyses were performed with GraphPad Prism 4.
RESULTS
Actual EE2 Concentrations in the Experimental Tanks
Measurements of the mean actual EE2 concentrations
revealed in controls 0.009 ± 0.013 ng EE2/l, in the 5-ng
EE2/l aquaria 4.34 ± 0.85 ng EE2/l, and in the 25-ng EE2/l
aquaria 16.23 ± 5.74 ng EE2/l.
Sex Ratio
In our study, we have used so-called monosex populations of
tilapia. In untreated controls, the percentage of females in the
female monosex group amounted to about 76% and that of
males in the male monosex group to 80%. A population with
75% or more fish of the same sex is considered to be monosex
(D’Cotta et al., 2001). Thus, our percentage is well within the
range that can be achieved in tilapia (Baroiller et al., 1995)
because sex chromosome–linked genetical factors determine
sex largely but not exclusively, and the development of final
sex phenotype is influenced by autosomal genetic factors in
combination with the hormonal, behavioral, and environmental
cues (Baroiller et al., 1999; Devlin and Nagahama 2002).
Both, the female and male monosex fish populations
exhibited a higher percentage of females after exposure to
both 5 and 25 ng EE2/l, the changes being significant in female
monosex (Table 1).
Body Length and Weight
Exposure to EE2 affected growth more pronouncedly in
male than in female fish. In male fish (Fig. 1a–c), from 50 DPF
on (i.e., 40 days after start of exposure), both body length and
weight were significantly reduced in fish exposed either to 5 or
25 ng EE2/l. At the end of the experiment (100 DPF), body
length of males (Fig. 1a) was reduced by about 9.5 (5 ng EE2/l)
and 11% (25 ng EE2/l) and body weight (Fig. 1c) by about
25% at both EE2 concentrations (Fig. 1). In female fish (Figs.
1d–f), both parameters showed only a trend to decrease. Here at
100 DPF, body length (Fig. 1d) was reduced by about 3 (5 ng
EE2/l) and 6.2% (25 ng EE2/l) and body weight (Fig. 1f) by
about 14% at 25 ng EE2/l.
Liver IGF-I and ERa Gene Expression
In both sexes, an initial (30 DPF) significant upregulation of
IGF-I mRNA levels (5 ng EE2/l, male: 2.82-fold, p ¼ 0.0004;
female: 2.43-fold, p ¼ 0.003; 25 ng EE2/l, male: 1.74-fold, p ¼
0.05, female: 2.16-fold, p ¼ 0.006) under both EE2
concentrations and in both sexes was observed (Figs. 2a and
2c). This was accompanied by elevated hepatic ERa levels
(Figs. 2b and 2d) in both males and females at 5 ng EE2/l
(male: 1.77-fold, p ¼ 0.003; female: 2.24-fold, p ¼ 0.0007)
and in females (Fig. 2d) also at 25 ng EE2/l (2.66-fold, p ¼
0.0007).
During prolonged exposure (i.e., at 50, 75, and 100 DPF),
the initial EE2-related upregulation of liver IGF-I mRNA
changed into a downregulation. In males, IGF-I gene
expression was significantly reduced under 25 ng EE2/l
( 2.38-fold, p ¼ 0.0003) at 50 DPF (Fig. 2a) and with both EE2
concentrations at all subsequent time points. Changes in IGF-I
gene expression were paralleled by significant downregulations
of ERa gene expression levels (Fig. 2b) at 75 DPF (5 ng
TABLE 1
Percentage of Females and Males in the Respective Monosex
Fish Populations
Monosex
tilapia
Female
(%)
CIa
(%) pb
Male
(%)
CIa
(%) pb
Control 76.2 61.3–86.7 80.0 70.8–87.0
5 ng EE2/l 94.2 83.8–98.6 0.0160 75.0 63.1–83.2 0.4235
25 ng EE2/l 95.1 83.0–99.5 0.0258 70.2 60.3–80.4 0.2010
Note. CI, confidence interval.
aCIs are calculated using modified Wald method (Agresti and Coull 1998)
using GraphPad QuickCalc.
bSignificances of sex ratio changes are calculated using Fisher’s exact test
using GraphPad Prism.
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EE2/l:  1.64-fold, p ¼ 0.0047; 25 ng EE2/l:  2.7-fold, p ¼
0.0003) and 100 DPF (5 ng EE2/l:  2.08-fold, p ¼ 0.0082).
Similar dynamics like in males, although delayed, were
observed in females: suppressed IGF-I mRNA levels (Fig. 2c)
occurred in females at 75 (25 ng EE2/l:  1.41-fold, p ¼
0.0093) and 100 DPF (5 ng EE2/l:  1.85-fold, p ¼ 0.015).
The observed lowered IGF-I mRNA levels, in part, coincided
with suppression (100 DPF, 25 ng EE2/l:  1.59-fold, p ¼
0.05) of ERa mRNA (Fig. 2d).
Brain IGF-I and ERa Gene Expression
In male brains, IGF-I mRNA levels were significantly
suppressed at 30 ( 1.41-fold, p¼ 0.0499) and 50 DPF ( 1.72-
fold, p ¼ 0.0148) at the higher EE2 concentration (25 ng EE2/l)
but returned to control levels at 75 DPF (Fig. 3a). ERa mRNA
was significantly elevated at 30 DPF at both concentrations (5 ng
EE2/l: 1.76-fold, p ¼ 0.0499; 25 ng EE2/l: 1.73-fold, p ¼
0.0379) and at 75 DPF at 5 ng EE2/l (1.65-fold, p ¼ 0.0205)
(Fig. 3b). At end of the experimental period (100 DPF),
a significant downregulation ( 1.89-fold, p ¼ 0.0011) of ERa
mRNA was observed under 5 ng EE2/l (Fig. 3b).
In female brains, IGF-I gene expression levels (Fig. 3c)
revealed an initial upregulation at 30 DPF (25 ng EE2/l: 2.16-
fold, p ¼ 0.0012) followed by significant suppression at 50
DPF at both concentrations (5 ng EE2/l:  1.59-fold, p ¼
0.0002; 25 ng EE2/l:  1.47-fold, p ¼ 0.0133). Under 5 ng
EE2/l, IGF-I mRNA was still reduced at 75 DPF ( 2.38-fold,
p ¼ 0.0001) followed by a significant elevation at 100 DPF
(1.66-fold, p ¼ 0.0281). The ERa mRNA levels tended to be
suppressed over the whole treatment phase. At several points in
time (5 ng EE2/l at 50 DPF:  1.53, p ¼ 0.0152; 25 ng EE2/l at
100 DPF:  1.41-fold, p ¼ 0.0496), the suppression was
significant (Fig. 3d).
Gonad IGF-I and ERa Gene Expression
In male gonads, IGF-I mRNA levels (Fig. 4a) were
significantly reduced at 50 and 75 DPF (50 DPF: 5 ng EE2/l:
 3.04-fold, p ¼ 0.0286; 25 ng EE2/l:  6.07-fold, p ¼
0.0286; 75 DPF: 25 ng EE2/l:  2.33-fold, p ¼ 0.0303). Only
at 100 DPF, IGF-I mRNA levels returned to control levels (5
ng/l) or were even significantly elevated (25 ng/l). ERa mRNA
in testes was suppressed over the whole exposure period. This
decrease was statistically significant at 30 DPF under 25 ng
EE2/l ( 2.09-fold, p ¼ 0.0339) and at 50 ( 2.73-fold, p ¼
0.0286) and 100 DPF ( 1.95-fold, p ¼ 0.037) under 5 ng
EE2/l (Fig. 4b).
In female gonads, IGF-I mRNA expression was significantly
elevated at 100 DPF (5 ng/l: 3.17-fold, p ¼ 0.0023; 25 ng EE2/l:
2.55-fold, p ¼ 0.0042) (Fig. 4c). ERa mRNA levels did not
change throughout the experimental period (Fig. 4d).
Pituitary GH Levels
The amount of GH mRNA was determined using extracts
from whole brain with pituitary attached since the pituitaries at
FIG. 1. Influence of EE2 exposure on somatic indices. Body length in centimeters (a, d) and weight in grams (b, c, e, f) in male (a–c) and female (d–f). White
columns: control, gray columns: 5 ng EE2/l, black columns: 25 ng EE2/l. The x-axis shows stages in DPF. Bars represent mean values with SD. Significance
levels: *p < 0.05, **p < 0.005, and ***p < 0.0001.
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30 and 50 DBF were too small to allow dissection. At 30 DPF,
no effect of EE2 exposure on GH expression was observed in
both sexes (Fig. 5). In females, after a significant increase in
GH mRNA at 50 DPF (5 ng EE2/l: 3.91-fold, p ¼ 0.002; 25 ng
EE2/l: 2.62-fold, p ¼ 0.05), GH mRNA decreased at 100 DPF
under 5 ng EE2/l to the threefold (p ¼ 0.03) and under 25 ng
EE2/l to the 10-fold (p ¼ 0.03) (Fig. 5a). In males, GH mRNA
exhibited only a trend to similarly increase at 50 DPF but was
significantly decreased at 100 DPF under 25 ng EE2/l by the
sevenfold (p ¼ 0.001) (Fig. 5b).
DISCUSSION
Developmental exposure to EE2 clearly shifted the sex ratio:
female and male monosex fish populations exhibited a higher
percentage of females after exposure to both 5 and 25 ng EE2/l.
The growth rate of the developing tilapia was also suppressed
by EE2 treatment. These findings are in agreement with our
previous observations on high-dose effects of EE2 (Shved
et al., 2007), but the present results indicate that concentrations
at environmental levels of EE2 still have the capacity to impair
tilapia growth and sexual development.
Our hypothesis was that the growth reduction resulting from
estrogen exposure is related to a cross talk between the
estrogen and the IGF-I system, be it through an estrogen effect
on the liver as source of the circulating (endocrine) IGF-I, or be
it an estrogen effect on the paracrine/autocrine IGF-I system in
the peripheral organs. Our experimental results show that
hepatic IGF-I expression can be suppressed by EE2 exposure.
This is particularly the case in males but with prolonged
exposure also in females. The decline in hepatic IGF-I mRNA
found here in developing tilapia is in agreement with previous
investigations in which estrogen exposure of adults of different
fish species led to a decrease in hepatic IGF-I mRNA
(Carnevali et al., 2005; Filby et al., 2006; Riley et al., 2004).
The stronger effect on liver IGF-I of males than of females
correlates with a stronger EE2 effect on growth indices in
males. This correlation suggests that the EE2-induced growth
reduction goes back to the EE2-induced reduction of hepatic
IGF-I expression, that is, to an endocrine effect and not to
a general toxic effect.
This interpretation is further supported by our findings on
GH mRNA, which reacts roughly in parallel to the endocrine
hepatic IGF-I system. In females, GH mRNA was significantly
raised at 50 DPF but not in males. The different response also
may explain the lesser growth impairment found in females
when compared to males. At 100 DPF, in both sexes, GH
mRNA was significantly downregulated. This decrease in GH
mRNA may well be caused by a direct action of EE2 on the
pituitary GH cells. Because E2 increased the expression of
somatostatin-14 in goldfish brain (Canosa et al., 2002) EE2
FIG. 2. Influence of EE2 exposure on IGF-I and ERa gene expression in liver (a–d). Relative changes (log2) of IGF-I (a, c) and ERa (b, d) mRNA expression
in EE2-exposed tilapia as compared to age-matched control tilapia. White columns: 5 ng EE2/l, black columns: 25 ng EE2/l. The x-axis shows stages in DPF. Bars
represent mean values with SD. Significance level: *p < 0.05, **p < 0.005, and ***p < 0.0005.
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may have as well suppressed GH at the hypothalamic level by
acting on somatostatin-14.
Very few studies have dealt with effects of estrogens on fish
pituitary GH. No effects on GH expression were observed in
adult fathead minnow exposed to 35 ng E2/l in surrounding
water for 14 days (Filby et al., 2006). However, in steroid-
primed immature rainbow trout after E2 injections (Holloway
and Leatherland, 1997) and in female goldfish after implanta-
tion of pellets containing 100 lg E2/g body weight for 5 days
(Zou et al., 1997), a stimulation of GH synthesis and secretion
by E2 has been reported. Similarly, in vitro treatment of
rainbow trout pituitary glands with 1000nM of the xenoes-
trogen o,p#-dichlorodiphenyltrichloroethane resulted in a sig-
nificant induction of GH mRNA (Elango et al., 2006). The
results of the latter studies reporting an increase in GH mRNA
after short-term treatment with (xeno)estrogens are consistent
with ours that show the significant increase in GH mRNA in
females at 50 DPF and a similar trend in males. While Shved
et al. (2007) did not investigate early stages, they reported
that feeding of tilapia with 125 lg EE2/g food from 10 to 40
DPF led to a significant reduction of pituitary GH mRNA
female (75 and 90 DPF) and male (165 DPF) fish. This
reduction is compatible with the present results where
a significant decrease in GH mRNA occurred after 90 days
of EE2 exposure. Some remaining discrepancies between
above studies and the present report are probably due to the
different estrogenic compounds used, to the different modes
of application, or to hormone application at different life
stages of the fish.
The question arises as to whether the altered hepatic IGF-I
expression in EE2-exposed fish is a direct consequence of the
EE2-mediated activation of the ER pathway. To this end, we
analyzed the expression of ERa. In our study, estrogen
treatment led to a downregulation of hepatic ERa expression
what is in contrast to the studies of Filby et al. (2006) and
Shved et al. (2007). In both these studies, estrogen-induced
decrease in IGF-I mRNA was accompanied by an upregula-
tion of ERa mRNA. However, a major difference between our
study and these two is that we used a long-term exposure
regime, while those treated the fish only for 14 and 30 days,
respectively. At 30 DPF, that is, after 20 days of exposure, we
also observed an upregulation of hepatic ERa, and only
thereafter, it turned into a downregulation. Thus, the
difference between our results and those of Filby et al.
(2006) and Shved et al. (2007) seems to be due to the
exposure duration. The hepatic IGF-I levels showed time-
dependent changes that are fairly similar to those of the ERa,
with an initial upregulation followed by a downregulation on
the longer run. This correlation suggests a mechanistic
relationship between the ER pathway and the IGF-I gene
expression, but future studies will have to substantiate this
hypothesis.
In contrast to the liver, the peripheral organs show quite
different responses of ERa and IGF-I mRNA to EE2
FIG. 3. Influence of EE2 exposure on IGF-I and ERa gene expression in brain (a–d). Relative changes (log2) of IGF-I (a, c) and ERa (b, d) mRNA expression
in EE2-treated as compared to age-matched control tilapia. White columns: 5 ng EE2/l, black columns: 25 ng EE2/l. The x-axis shows stages in DPF. Bars
represent mean values with SD. Significance level: *p < 0.05, **p < 0.005, and ***p < 0.0005.
98 SHVED ET AL.
treatment suggesting that the mechanisms of the IGF-I-
estrogen cross talk differ between the endocrine part of the
IGF-I system (liver) and the autocrine/paracrine part (gonads
and brain). ERa mRNA in male brain was significantly
elevated at 30 DPF at both concentrations to be significantly
decreased at the end of the experimental period (100 DPF)
under 5 ng EE2/l. In females, brain ERa mRNA tended to be
decreased with some significancies all over the experimental
period. In contrast, in adult fathead minnow, exposure to 35
ng E2/l for 14 days did not influence ERa mRNA in brain of
either sex (Filby et al., 2006). Thus, the brain ERa mRNA
seems to be downregulated only during long-term develop-
mental exposure. In the same study (Filby et al., 2006), IGF-I
mRNA in brain was significantly induced in both sexes, the
increase being more pronounced in female brain. This is quite
consistent with the present data where also a significant
upregulation of IGF-I mRNA in female brain was observed
after 20 days of EE2 exposure. Later, however, brain IGF-I
mRNA was downregulated, the effect being stronger in
females.
Developmental exposure to low concentrations of EE2 has
also consequences on the IGF-I expression in organs where this
hormone is considered to have an autocrine or paracrine
function such as brain and gonads. The response patterns in
these organs were different to the liver. However, also here
a sex-specific response pattern was indicated, at least in the
brain as outlined above. In the testis, IGF-I showed a significant
but transitory downregulation which disappeared or even
turned into an induction under prolonged exposure. In contrast,
in the ovaries of exposed fish, IGF-I mRNA levels showed an
increase becoming significant at 100 DPF. The functions of
IGF-I include roles in spermatogenesis and oocyte proliferation
and maturation. In Japanese eel and tilapia cultured testes, IGF-
I stimulated spermatogenesis induced by 11-ketosterone (Nader
et al., 1999; Tokalov and Gutzeit, 2005). In rainbow trout
testes, IGF-I mRNA increased after GH treatment (Biga et al.,
2004; Le Gac et al., 1996) and GH and IGF-I stimulated the
incorporation of thymidine into spermatogonia and primary
spermatocytes (Loir, 1999). In the ovary of different fish
species, IGF-I stimulated thymidine incorporation in vitello-
genic follicles (Srivastava and Van der Kraak, 1994), promoted
oocyte maturation (e.g., Lokman et al., 2007; Negatu et al.,
1998), and selectively influenced the production of sex steroids
(e.g., Chourasia and Joy, 2007; Weber et al., 2007). In
sturgeon, previtellogenic follicles exhibited higher IGF-I and
IGF-I receptor (IGF-1R) mRNA levels in maturing females
than in age-matched non-maturing females, and females
entering vitellogenesis showed an increase in ovarian IGF-I
and IGF-1R mRNA (Wuertz et al., 2007), thus emphasizing the
importance of local IGF-I. Recent evidence obtained in zebra
fish exposed to 10 ng EE2/l surrounding water indicated not
only a reduction of juvenile growth but also an impairment of
sexual maturity, adult fecundity, and fertilization success
(Schäfers et al., 2007). Similarly, the exposure of Japanese
medaka to environmentally relevant concentration of 1.6–157
ng/l E2 impaired fecundity and reduced the number of spawns
(Jukosky et al., 2008). Whether the EE2 effect on IGF-I
expression in gonads of developing tilapia is involved in the
FIG. 4. Influence of EE2 exposure on IGF-I gene expression in male and female gonads (a–d). Relative changes log2 of IGF-I (a, c) and ERa (b, d) mRNA
expression in EE2-exposed as compared to age-matched control tilapia. White columns: 5 ng EE2/l, black columns: 25 ng EE2/l. The x-axis shows stages in DPF.
Bars represent mean values with SD. Significance level: *p < 0.05 and **p < 0.005.
INTERFERENCE OF EE2 WITH GH/IGF-I IN BONY FISH 99
feminization effect of the experimental treatment cannot be
asserted from the present data; however, it is clear that EE2
changes normal expression patterns of IGF-I in gonad
ontogeny and thereby has the potential to lead to adverse
consequences.
Our study advances endocrine disruptor research in that it
extends the targets for action of EDCs beyond the re-
productive axis––which has received most attention to date.
Importantly, we could demonstrate that such effects occur at
low concentrations similar to environmental levels. Individual
growth has consequences for demographic parameters such as
age-specific survival, time to maturation, or fecundity. Thus,
our findings obtained with low doses of EE2 point to the
impact of the GH/IGF-I system, through which environmental
estrogens, in addition to their direct effect on fish re-
production, could alter population growth of fish species.
Future research has to address the mechanisms through which
estrogens act to modulate the GH/IGF-I system. In particular,
given our findings on the correlation between ER and IGF-I
changes, it would be important to examine whether the EE2
effects on the GH/IGF-I system in liver and extrahepatic sites
are mediated through the ER pathway and/or through other
mechanisms.
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